John Carroll

• Representing Quantum Capital Group in its $4.7 billion sale of Cogentrix Energy, a U.S. independent power producer, to Vistra Corporation.
• Representing 3M on antitrust aspects of its acquisition of Madison Fire & Rescue, in partnership with Bain Capital
• Representing NCR Atleos on antitrust aspects of its $6.6 billion acquisition by The Brinks Company
• Served as lead antitrust counsel to digital payments and unattended retail company Cantaloupe, Inc. in its $848 million all-cash acquisition by 365 Retail Markets.
• HEALTHCARE AND LIFE SCIENCES
• Currently serving as lead antitrust counsel for health systems in antitrust investigations of strategic transactions
• Led antitrust efforts for VillageMD in achieving antitrust clearance for its $8.9 billion acquisition of Summit Health.
• Successfully represented clinically and financially integrated provider networks in nonpublic government investigations.
• Advising private equity firms, health systems, and physician groups on a variety of antitrust issues, including potential transactions.
• Advising pharmaceutical and medical device companies on all aspects of competitor collaborations, including mergers, acquisitions, and joint ventures.

Consumer Products & Entertainment

• Represents clients in the food & beverage, luxury, technology, retail, and fashion industries on antitrust issues.
• Advises entertainment and media companies on antitrust aspects of transactions and commercial activities, such as pricing and distribution.
• Represented Energizer Holdings, Inc. on antitrust aspects of it $2 billion acquisition of Spectrum Brands.

Energy

• Advising a number of energy companies on a range of antitrust issues related to infrastructure projects, teaming arrangements, and other collaborations.
• Successfully represented leading gasoline retailer on achieving FTC clearance for its strategic transaction without enforcement action.
• Devised and implemented antitrust compliance strategies for coalitions of energy industry competitors.

Manufacturing

• Represented leading chemical and building products companies in transactions and defended them in government investigations.
• Represented WestRock Company on antitrust aspects of its $4.9 billion acquisition of KapStone Paper Packaging.

Global Cartel Investigations

• Defended multinational companies in criminal investigations alleging antitrust conspiracies.
• Represented an executive of international auto parts company in connection with a cartel investigation in that industry.

John D. Carroll is a partner in the Antitrust practice in the Washington, D.C., office of King & Spalding.  His practice focuses on civil and criminal antitrust matters, including mergers & acquisitions, strategic counseling and compliance, and global cartel investigations, where he represents clients before the Department of Justice Antitrust Division, Federal Trade Commission, and international and state antitrust enforcement authorities.

John has been recognized by Legal 500 and Global Competition Review, and was named a “Rising Star” by Washington Super Lawyers.  He frequently speaks and writes on antitrust issues and has held leadership positions in the American Bar Association Section of Antitrust Law (currently Vice-Chair, Healthcare & Pharmaceuticals Committee) and the American Health Lawyers Association Antitrust Practice Group (former Social Media Chair).

John joined King & Spalding from Ropes & Gray.  Prior to joining Ropes & Gray, he was in the Mergers I Division of the Federal Trade Commission’s Bureau of Competition for several years.  While with the FTC, he investigated, challenged, and negotiated settlements in a number of potentially anti-competitive business combinations in the technology, consumer products, defense, healthcare, and pharmaceutical industries and received an Award for Meritorious Service for work on merger litigation.

Recent Speaking Engagements

• Moderator, “Recent Developments in Health Care & Pharmaceuticals," American Bar Association, Section of Antitrust Law, May 18, 2020  
• Panelist, "Federal Antitrust Enforcement of the FinTech Industry," Electronic Transactions Association, April 10, 2019
• Panelist, "Healthcare Antitrust Educational Call," American Health Lawyers Association, December 11, 2018
• Panelist, "Exclusionary Practices: An Overview," American Health Lawyers Association Annual Meeting, June 27, 2018
• Panelist, "Recent Developments in Healthcare & Pharmaceuticals," American Bar Association, Antitrust Section, January 24, 2018
• Panelist, "300 Days and Counting, Antitrust in the Trump Administration, What We've Seen and What to Expect," King & Spalding Pharma U, November 1, 2017

Recent Publications

• Editor, The Healthcare Antitrust Handbook (forthcoming) ABA Publications
• Author, "Antitrust & Covid-19 in the U.S.: Four Key Issues for Healthcare Providers,"
   Competition Policy International, May 14, 2020
• Co-Editor, Antitrust Law Developments, 2020 Update, ABA Publications 
• Contributing Editor, Pharmaceutical Industry Handbook (2018), ABA Publications
• Supervising Editor, The Energy Industry Handbook (2017) ABA Publications